• OPEN AN ACCOUNT
Indian Indices
Sensex
72,382.47 472.77
( 0.66%)
Global Indices
Nasdaq
51,190.24 242.68
(0.48%)
Dow Jones
7,742.36 54.91
(0.71%)
Hang Seng
69,916.07 1,606.61
(2.35%)
Nikkei 225
10,489.44 27.49
(0.26%)
Forex
USD-INR
96.17 0.25
(0.26%)
EUR-INR
108.49 -0.30
(-0.28%)
GBP-INR
127.16 -0.03
(-0.02%)
JPY-INR
0.61 0.00
(-0.36%)

EQUITY - MARKET SCREENER

Emmsons International Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
532038
INE073C01015
-1951.1833333
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
2.64
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

As on: Oct 05, 2026 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
831.15 16.15 8742 20.30
Stock Price Details
Open Price() 819.85
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 836.00
Today's Low () 813.20
52-Week High () 998
152-Week Low () 635.3
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 1.47
Eps 40.14
Book Value 285.6722314
Market Cap (.Cr) 16,019.89
Face Value 2
Market Lot 1
AGM Date Aug
Book Closure Date
ISIN No. INE901L01018


News
Alembic Pharmaceuticals consolidated net profit rises 12.11% in the June 2026 quarter
Alembic Pharmaceuticals receives USFDA approval for Prucalopride Tablets
Alembic Pharmaceuticals announces board meeting date
Alembic Pharma gains after partner NATCO receives USFDA tentative nod for Olaparib tablets
Alembic Pharmaceuticals to conduct AGM
Alembic Pharma rises after receiving USFDA approval for Dapsone Gel, 5%
Alembic Pharmaceuticals receives USFDA final approval for Dapsone Gel
Alembic Pharmaceuticals receives USFDA approval for Oseltamivir Phosphate for Oral Suspension, 6 mg/mL
Alembic Pharmaceuticals receives USFDA approval for Binimetinib Tablets, 45 mg
Alembic Pharma gains after receiving USFDA tentative approval for Binimetinib tablets
More
Corporate Details
Incoporation Year   : 2010
Chairman : C R Amin
Bussiness Group : Alembic Group
Registered Office
Alembic Pharmaceuticals Ltd
Alembic Road,
,
Vadodara,
Gujarat-390003
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-0265-2280550
Fax:91-0265-2282506
Fax:91-22-66317458
E-Mail : apl.investors@alembic.co.in
URL : http://www.alembicpharmaceuticals.com/


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE HC
  • BSE SmallCap
No Data Found...!
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi